The FamiCord Group strengthens its position in Turkey

FamiCord Group has concluded an investment agreement regarding the purchase of shares in the Turkish stem cell bank which has operated so far within the structure of the Acıbadem Healthcare Group.

FamiCord group has now 70% of shares in the newly created Famicord – Acibadem company. The company was formed from a separate part of the enterprise with the Acıbadem Healthcare Group, to which the scope of activities including processing, testing and storage of cord blood was transferred. The remaining 30% of shares will be owned by the Acıbadem Healthcare Group. The purchase is financed from the resources acquired within a private subscription of PBKM shares which took place last year.

Recently added

17 November 2025 FamiCord Group Recognized as Europe’s Leading Stem Cell Bank FamiCord is the largest stem cell bank in Europe and the third largest in the world. The quality of its services is validated by international certifications, and the company has now been recognized as Europe’s Leading Stem Cell Bank by Life Sciences Review, highlighting its commitment to excellence, clinical reliability, and innovation in stem cell banking.FamiCord Group have been awarded as “The Europe’s Leading Stem Cell Bank” , independent experts jury underlined FamiCord has established itself as a leading provider in the field, guiding families through the collection, processing, and long-term preservation of cord blood and perinatal tissues. Read more
27 August 2025 Infantile cerebral palsy – Convincing evidence for the use of perinatal stem cells Leipzig, July 15, 2025 - Cerebral palsy (CP) continues to be one of the most common motor disabilities in childhood and is associated with permanent movement restrictions and spasticity. The therapeutic potential of stem cells from umbilical cord blood and tissue was discussed at the 37th Annual Meeting of the European Academy Of Childhood-onset Disabilities (EACD) and the 4th Meeting of the International Alliance of Academies of C hildhood Disability (IAACD) from June 24 - 28, 2025 in Heidelberg. As part of a symposium supported by FamiCord AG, international experts presented the current state of research and reported on the results from clinical practice. Read more